コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ment of glutamate, glutamine and GABA (gamma-aminobutyric acid).
2 ajor inhibitory neurotransmitter GABA (gamma-aminobutyric acid).
3 as a receptor of the priming activator beta-aminobutyric acid.
4 ant on the inhibitory neurotransmitter gamma-aminobutyric acid.
5 press galanin and the neurotransmitter gamma-aminobutyric acid.
6 fatty acid compositions and levels of gamma-aminobutyric acid (54.9 mg/100 g), free phenolics (507.4
7 lateral infusions into the RMTg of the gamma-aminobutyric acid A (GABAA) agonist, muscimol, indeed ac
8 Nlrp3 inflammasome were independent of gamma-aminobutyric acid A receptor activation or N-methyl-d-as
9 ve action on the omega1 subtype of the gamma-aminobutyric acid A receptor, zolpidem tartrate presents
12 o neurotransmitter receptor genes, the gamma-Aminobutyric acid-A receptor delta and gamma-aminobutyri
14 -isoxazolepropionic acid, glycine, and gamma-aminobutyric acid-A receptors), were prevalent in patien
15 terminants containing substitutions of alpha-aminobutyric acid (AABA), a cysteine analogue containing
17 in barrier and inhibit the activity of gamma-aminobutyric acid aminotransferase (GABA-AT), the enzyme
18 ivator that regulates transcription of gamma-aminobutyric acid aminotransferase (GABA-AT; GabT) upon
20 e stress, and is associated with GABA (gamma-aminobutyric acid, an inhibitory neurotransmitter) signa
23 some neurotransmitter systems, such as gamma-aminobutyric acid and glutamate, mainly in the cortex.
24 ethod to monitor glutamate, glutamine, gamma-aminobutyric acid and lactate in the brains of unaffecte
25 sidues p2C and p5M to the conservative alpha-aminobutyric acid and norleucine, respectively, signific
26 agonist bicuculline, the agonist GABA (gamma-aminobutyric acid), and the classical benzodiazepines al
27 ll as regulating release of glutamate, gamma-aminobutyric acid, and acetylcholine from presynaptic ax
28 d by l-glutamate (l-Glu), l-aspartate, gamma-aminobutyric acid, and acetylcholine, with l-Glu eliciti
30 eractions between the endocannabinoid, gamma-aminobutyric acid, and glutamate systems and their indiv
31 nesis including synthesis of glutamate/gamma-aminobutyric acid as a potential transcriptional target
32 the neurons also release glutamate and gamma-aminobutyric acid as cotransmitters, with striking regio
33 ropic glutamate receptors (mGluRs) and gamma-aminobutyric acid B (GABA(B)) receptors (GABA(B)Rs) most
35 Aminobutyric acid-A receptor delta and gamma-aminobutyric acid B receptor subunit 1; their differenti
37 n genes responsive to the priming agent beta-aminobutyric acid (BABA) revealed IMPAIRED OOMYCETE SUSC
39 luding two pathways, phenylacetate and gamma-aminobutyric acid catabolism, which were found to be imp
41 the specific impairment of perisomatic gamma-aminobutyric acid circuits are hallmarks of the schizoph
42 d lower limb was associated with lower gamma-aminobutyric acid concentration in the sensorimotor cort
44 r adults to a likely decrease in GABA (Gamma Aminobutyric Acid) concentration in visual cortex, an as
45 ls were used to compare differences in gamma-aminobutyric acid concentrations between patients and co
49 the distribution of neurotransmitters-gamma-aminobutyric acid, dopamine and serotonin-with high spec
50 real-time-corrected three-dimensional gamma-aminobutyric acid-edited magnetic resonance (MR) spectro
52 iety of neurotransmitters, such as the gamma-aminobutyric acid-ergic system, the study of prefrontal
53 part by direction-selective release of gamma-aminobutyric acid from starburst amacrine cells onto dir
56 mine whether antecedent stimulation of gamma-aminobutyric acid (GABA) A receptors with the benzodiaze
62 PVN -> NAc neurons and quantified both gamma-aminobutyric acid (GABA) and glutamate release and phosp
63 amino acid neurotransmitter systems of gamma-aminobutyric acid (GABA) and glutamate, respectively, pl
68 elease the inhibitory neurotransmitter gamma-aminobutyric acid (GABA) at non-image-forming brain targ
69 pertensive activity due to their large gamma-aminobutyric acid (GABA) content (6.8-10.6 mg/g) and ang
70 ble structures, including amido-diols, gamma-aminobutyric acid (GABA) derivatives, and heterocycles.
71 f the cockroach Periplaneta americana, gamma-aminobutyric acid (GABA) has been identified as the pote
73 to map histamine (HA), FMRF-amide, and gamma-aminobutyric acid (GABA) immunoreactivity in the central
75 ilk and regular-fat cheese enriched in gamma-aminobutyric acid (GABA) influences daytime ambulatory b
77 o reductions of parvalbumin containing gamma-aminobutyric acid (GABA) interneurons and volumes of the
78 rtate receptor (NMDAR) hypofunction on gamma-aminobutyric acid (GABA) interneurons disinhibiting pyra
86 In contrast, KATPHI islets had low gamma-aminobutyric acid (GABA) levels and lacked (13)C incorpo
87 Low-pressure plasma also increased gamma-aminobutyric acid (GABA) levels from approximately 19 to
88 in excitatory glutamate and inhibitory gamma-aminobutyric acid (GABA) levels, including in brain regi
89 bitory), schizophrenia (excitatory and gamma-aminobutyric acid (GABA) mediated) and bipolar disorder
90 he density of cartridges detectable by gamma-aminobutyric acid (GABA) membrane transporter 1 immunore
91 enzyme GAD67, a critical actor of the gamma-aminobutyric acid (GABA) metabolism as it catalyses the
93 stimulation of mouse zona incerta (ZI) gamma-aminobutyric acid (GABA) neurons or their axonal project
95 show that optogenetic inhibition of LH gamma-aminobutyric acid (GABA) neurons restricted to cue prese
96 s expression in VTA 5-HT2CR expressing gamma-aminobutyric acid (GABA) neurons, but not 5-HT2CR expres
99 ACE) resulted in an enhancement of the gamma-aminobutyric acid (GABA) neurotransmitter system in the
102 s did not confirm colocalizations with gamma-aminobutyric acid (GABA) or the circadian coupling pepti
103 Given the heterogeneity within the gamma-aminobutyric acid (GABA) receptor and transporter famili
104 neurites are also immunopositive for a gamma-aminobutyric acid (GABA) receptor subunit (GABAA Ralpha1
105 Nonselectively reducing intrastriatal gamma-aminobutyric acid (GABA) receptor-A inhibition synchroni
107 rinking, and basal and alcohol-induced gamma-aminobutyric acid (GABA) release in the central nucleus
110 es revealed a significant reduction in gamma-aminobutyric acid (GABA) release probability without alt
111 f the metabotropic GABA(B) receptor by gamma-aminobutyric acid (GABA) results in prolonged inhibition
113 ncreased mitochondrial activity causes gamma aminobutyric acid (GABA) sequestration in the mitochondr
115 , Gao and colleagues identify that the gamma-aminobutyric acid (GABA) shunt is upregulated with the o
116 xendin-4, a GLP-1 receptor agonist, on gamma-aminobutyric acid (GABA) signaling in hippocampal CA3 py
118 inflammation, synaptic plasticity and gamma-aminobutyric acid (GABA) signaling, and liver inflammati
119 target, NKCC1, initiates the switch in gamma-aminobutyric acid (GABA) signaling, limits early spontan
120 ndmark is the excitatory to inhibitory gamma-aminobutyric acid (GABA) switch caused by reciprocal cha
121 ociated with reduced concentrations of gamma-aminobutyric acid (GABA) that are normalized by antidepr
122 onally stained with antibodies against gamma-aminobutyric acid (GABA) to identify GABAergic interneur
123 A) exhibited a significant increase in gamma-aminobutyric acid (GABA) transmission compared with rats
124 te signaling (P-value=7.22 x 10(-15)), gamma-aminobutyric acid (GABA) transport (P-value=1.36 x 10(-1
125 We saw that stimulation of vesicular gamma-aminobutyric acid (GABA) transporter (VGAT)-expressing B
126 encoded by SLC6A1, is one of the major gamma-aminobutyric acid (GABA) transporters in the brain and i
127 evels of glutamate+glutamine (Glx) and gamma-aminobutyric acid (GABA) were measured before, during, a
128 eic acids, as well as higher amount of gamma-aminobutyric acid (GABA) were observed in biodynamic gra
129 f endogenous alpha5-subunit-containing gamma-aminobutyric acid (GABA)(A) receptors (alpha5-GABARs).
130 excitatory (glutamate) and inhibitory (gamma aminobutyric acid (GABA)) neurotransmitter circuits in a
132 tant ion channels, gated by glutamate, gamma-aminobutyric acid (GABA), and acetylcholine, also have a
133 ibitory neurotransmitter of the brain, gamma-aminobutyric acid (GABA), can be released through the re
134 the relative quantity of glutamate to gamma-aminobutyric acid (GABA), DA, and glutamate neurons with
135 zyme synthesizing the neurotransmitter gamma-aminobutyric acid (GABA), define how artemisinins also i
136 rentially methylated probes implicated gamma-aminobutyric acid (GABA), dopamine and serotonin neurotr
138 r various neurotransmitters-glutamate, gamma-aminobutyric acid (GABA), dopamine, serotonin, acetylcho
139 dicted to form anion channels gated by gamma-aminobutyric acid (GABA), glutamate, histamine, or chang
140 ajor sleep-promoting neurotransmitter, gamma-aminobutyric acid (GABA), in the GABA shunt generates ca
141 ay of the inhibitory neurotransmitter, gamma-aminobutyric acid (GABA), in this putative imbalance: GA
142 effects of postharvest treatments with gamma-aminobutyric acid (GABA), methyl jasmonate (MeJA) or met
144 rs for the inhibitory neurotransmitter gamma-aminobutyric acid (GABA), particularly within the fronta
145 ecently, it has been demonstrated that gamma-aminobutyric acid (GABA), the chief inhibitory neurotran
148 acting neurotransmitters glutamate and gamma-aminobutyric acid (GABA), two major neurotransmitters in
149 a potential lipophilic bioisostere of gamma-aminobutyric acid (GABA), various late-stage diversifica
151 nal fluid (CSF)-induced enhancement of gamma-aminobutyric acid (GABA)-A receptor activity was found i
152 spartate (NMDA) glutamate receptor and gamma-aminobutyric acid (GABA)-A receptor during progression o
153 ith a positive allosteric modulator of gamma-aminobutyric acid (GABA)-A receptors in cerebrospinal fl
154 unique role of GABARAPs, in particular gamma-aminobutyric acid (GABA)-A-receptor-associated protein-l
155 n is likely due to a reduced number of gamma-aminobutyric acid (GABA)-ergic boutons, which may result
156 eractions between parvalbumin-positive gamma-aminobutyric acid (GABA)-ergic interneurons and pyramida
157 uses stress-sensitive, PVH-projecting, gamma-aminobutyric acid (GABA)-ergic neurons as representing a
159 hanges the number of dopamine (DA)- or gamma aminobutyric acid (GABA)-expressing neurons, with corres
162 spartate (NMDA) excitation balanced by gamma-Aminobutyric acid (GABA)-mediated inhibition and leads t
163 , salt reabsorption in the kidney, and gamma-aminobutyric acid (GABA)-mediated modulation in neurons.
164 but not the parvalbumin subset of SNr gamma-aminobutyric acid (GABA)-releasing (GABAergic) neurons w
173 h slightly different sensitivities, on gamma-aminobutyric acid (GABA)A , alpha-amino-3-hydroxy-5-meth
174 to involve functional deficits in both gamma-aminobutyric acid (GABA)ergic and glutamatergic synaptic
175 change factor selectively localized to gamma-aminobutyric acid (GABA)ergic and glycinergic postsynaps
176 ergent findings indicate that cortical gamma-aminobutyric acid (GABA)ergic circuitry is altered in sc
177 inergic systems and is extended to the gamma-aminobutyric acid (GABA)ergic elements involved with the
178 inergic systems and is extended to the gamma-aminobutyric acid (GABA)ergic elements of these nuclei.
179 Finally, we revealed a role for the gamma-aminobutyric acid (GABA)ergic functions of LTSIs in lear
180 s glutamatergic excitatory neurons and gamma-aminobutyric acid (GABA)ergic inhibitory interneurons.
181 uperior colliculus receives inhibitory gamma-aminobutyric acid (GABA)ergic input from the basal gangl
183 egmental nucleus (RMTg), which contain gamma-aminobutyric acid (GABA)ergic neurons that mediate rewar
184 types (cholinergic, glutamatergic, and gamma-aminobutyric acid (GABA)ergic neurons) across its differ
185 ognitive alterations and damage to the gamma-aminobutyric acid (GABA)ergic system in the hippocampus
186 he retina, the ratio of glycinergic to gamma-aminobutyric acid (GABA)ergic to amacrine cells remained
188 tic connectivity and function of a few gamma-aminobutyric acid (GABA)ergic wide-field amacrine cells
189 ent solely in neurons, specifically in gamma-aminobutyric acid (GABA)ergic, glutamatergic, and catech
190 d mPFC glutamate + glutamine (Glx) and gamma-aminobutyric acid (GABA+) concentrations in 64 women wit
192 iated with mutations in the inhibitory gamma-aminobutyric acid (GABAA) receptor gamma2 subunit gene,
193 ne, a positive allosteric modulator of gamma-aminobutyric acid (GABAA) receptors, for the treatment o
194 synaptic inhibition mediated by type A gamma-aminobutyric acid (GABAA) receptors, which are Cl(-)-per
196 ting to the risk of each first IA, and gamma-aminobutyric acid (GABAs) associated with the first auto
197 Val > Lys, Tyr, Pro > hydroxyproline > alpha-aminobutyric acid > Gln, Thr, Ser > Glu, Ala, Gly, Asn,
198 altered brain levels of glutamate and gamma-aminobutyric acid have been identified in both animal an
199 uropil organization and the pattern of gamma-aminobutyric acid immunostaining of the medulla and LOX
200 tostatin (SST), a marker of inhibitory gamma-aminobutyric acid interneurons that target pyramidal cel
203 s of this study were to investigate if gamma-aminobutyric acid levels (i) are abnormal in patients wi
204 Specifically for each unit decrease in gamma-aminobutyric acid levels (in mM), there was a predicted
208 rmalities (e.g., serotonin, glutamate, gamma-aminobutyric acid) likely interact to facilitate illness
209 nterneurons (FSIs), a strong source of gamma-aminobutyric acid-mediated synaptic inhibition in the NA
210 impulsive actions, most likely through gamma-aminobutyric acid-mediated synaptic inhibition of medium
211 athways related to ethanol production, gamma-aminobutyric acid metabolism, and endotoxin biosynthesis
214 nd a specific population of inhibitory gamma-aminobutyric acid neurons (i.e., parvalbumin-containing
215 endent signaling in dorsal hippocampal gamma-aminobutyric acid neurons but no evident behavioral phen
217 ting and inhibiting neighbouring GABA (gamma-aminobutyric acid) neurons in the ventral tegmental area
218 he pre- and postsynaptic components of gamma-aminobutyric acid neurotransmission and in the density o
219 y supports the idea that modulation of gamma-aminobutyric acid neurotransmission may be an important
220 is in part mediated by specific GABA (gamma-aminobutyric acid)-producing neurons in the bed nucleus
221 e, we asked whether mesoaccumbal GABA (gamma-aminobutyric acid) projections enhance adaptive respondi
222 ion causes changes in the rodent brain gamma-aminobutyric acid receptor (GABAAR) subunit composition
223 echanisms controlling the metabotropic gamma-aminobutyric acid receptor (GABAB) cell surface stabilit
224 he type of excitability: a depolarized gamma-Aminobutyric acid receptor (GABAR) reversal potential or
225 d-aspartate receptor in 4 patients and gamma-aminobutyric acid receptor A in 1 patient of 111 patient
226 e (AgRP) neurons because inhibition of gamma-aminobutyric acid receptor in the ARC did not prevent th
227 behavioral results suggest that local gamma-aminobutyric acid receptor signaling mediates the hypoph
229 duced lysosomal degradation of RhoB in Gamma-aminobutyric acid receptor-associated protein (GABARAP)+
230 ociated protein 1 light chain 3 (LC3), gamma-aminobutyric acid receptor-associated protein (GABARAP)]
231 ell-surface antibodies, mainly against gamma-aminobutyric acid receptors (53% vs 11%; P < .001).
233 become appreciated that activation of gamma-aminobutyric acid receptors (GABA-Rs) on ss-cells can pr
237 B1R); 3) binds to CB1R, which inhibits gamma-aminobutyric acid release from the cholecystokinin-conta
238 se brain, prevented ethanol-stimulated gamma-aminobutyric acid release in the central amygdala, and r
240 donoylglycerol-dependent inhibition of gamma-aminobutyric acid release without altering postsynaptic
242 ell types include hypocretin and GABA (gamma-aminobutyric-acid)-releasing neurons of the lateral hypo
244 including the migration of GABAergic (gamma-aminobutyric-acid-releasing) neurons from ventral to dor
248 nate-semialdehyde dehydrogenase in the gamma-aminobutyric acid shunt pathway and an aconitase family
249 mentation, alanine metabolism, and the gamma-aminobutyric acid shunt, while [(13)C]glutamate and [(15
250 be temporarily reverted by inhibiting gamma-aminobutyric acid signaling but not by a Ras-ERK blockad
253 process, the excitatory-to-inhibitory gamma-aminobutyric acid switch; defects in this switch have be
255 urrent techniques for monitoring GABA (gamma-aminobutyric acid), the primary inhibitory neurotransmit
256 strong antagonism toward receptors of gamma-aminobutyric acid, the major inhibitory transmitter.
258 reated with melatonin exhibited higher gamma-aminobutyric acid transaminase (GABA-T) enzyme activity
259 es the CG7433 protein, a mitochondrial gamma-aminobutyric acid transaminase (GABAT), and reduces GABA
261 bitory synaptic currents and vesicular gamma-aminobutyric acid transporter (vGAT) staining intensity
262 isorder genes, SLC6A1, which encodes a gamma-aminobutyric acid transporter, was associated with misse
263 nts in the gene GABRB2, coding for the gamma-aminobutyric acid type A (GABA(A) ) receptor subunit bet
267 ugs act through positive modulation of gamma-aminobutyric acid type A (GABA(A)) receptors to dampen n
268 ial firing by local application of the gamma-aminobutyric acid type A (GABA-A) agonist muscimol incre
269 entified four de novo mutations in the gamma-aminobutyric acid type A (GABAA ) receptor beta3 subunit
273 steroids are efficacious modulators of gamma-aminobutyric acid type A receptor (GABA(A)) receptor fun
274 highly selective for the slow type of gamma-aminobutyric acid type A receptor (GABA(A)R) could have
276 deficient neurons show reduced surface gamma-aminobutyric acid type A receptor (GABAAR) levels and im
277 that inhibit alpha5 subunit-containing gamma-aminobutyric acid type A receptor function improve cogni
278 sporter expression and impaired spinal gamma-aminobutyric acid type A receptor function, indicative o
279 wever, DCS-LTD persists despite either gamma-aminobutyric acid type A receptor or N-methyl-D-aspartat
280 uding GABRB3, GABRA5, GABRG3, encoding gamma-aminobutyric acid type A receptor subunits (beta3, alpha
284 eroids (NS) are the main modulators of gamma-aminobutyric acid type A receptors (GABA(A)Rs), which ar
285 c acetylcholine receptors (nAChRs) and gamma-aminobutyric acid type A receptors (GABAARs) are members
286 t act as convulsants and inhibitors of gamma-aminobutyric acid type A receptors (GABAARs) rather than
288 suggest that alpha5 subunit-containing gamma-aminobutyric acid type A receptors are novel targets for
289 he scaffolding protein Gephyrin and of gamma-aminobutyric acid type A receptors at inhibitory neurona
290 nhibition of alpha5 subunit-containing gamma-aminobutyric acid type A receptors attenuated cognitive
291 nhibition of alpha5 subunit-containing gamma-aminobutyric acid type A receptors attenuated deficits i
292 t inhibiting alpha5 subunit-containing gamma-aminobutyric acid type A receptors would improve cogniti
293 elective for alpha5 subunit-containing gamma-aminobutyric acid type A receptors, 30 minutes before un
295 ic animals, supporting the notion that gamma-aminobutyric acid type A signaling can also initiate ict
296 ing synaptic inhibition through GABAA (gamma aminobutyric acid type A) and glycine receptors depends
297 ned neuronal inhibition is mediated by gamma-aminobutyric acid type B (GABAB) receptors, which are he
298 ol, like rapid antidepressants, alters gamma-aminobutyric acid type B receptor (GABABR) expression an
299 und the sushi 1 domain specific to the gamma-aminobutyric acid type B receptor subunit 1a (GABA(B)R1a